CoChat
Sign Up
Cited by 18Ovarian cancer diagnosis and treatmentMinimally Invasive Surgical TechniquesEndometrial and Cervical Cancer Treatments

Port site resection after laparoscopy in advance ovarian cancer surgery: time to abandon?

Lago, Víctor, Gimenez, Laura, Matute, Luis, Padilla-Iserte, Pablo, Cárdenas-Rebollo, José Miguel, Gurrea, Marta, Montero, Beatriz, Montoliu, Guillermina +1 more·2019·Surgical Oncology
DOI 10.1016/j.suronc.2019.01.007
Open this paper in CoChat — free account

Abstract

Introduction The use of laparoscopy in the treatment and management of advanced ovarian cancer is increasing among the gynaecologic oncologists. The development of port site metastases after laparoscopy is a concern and a matter of debate due to theoretical iatrogenic disease spread. Port site resection (PSR) has been proposed as an option to avoid this scenario.Material and methods One hundred and twenty-three patients with advanced ovarian cancer (FIGO III-IV) and with diagnostic laparoscopy were included and after cytoreductive surgery were classified into two groups: no port site resection (No-PSR) and port site resection (PSR). Based on the pathological results of all port site specimens, PSR was classified as positive port site metastasis (PSM+) and negative port site metastasis (PSM-).Results In 82 cases, the laparoscopic port site access was resected in the debulking surgery. At the final specimen examination, 49% presented as PSM+. No statistical differences regarding survival were found, either between the No-PSR and PSR groups (p = 0.28) or between the PSM+ and PSM - groups (p = 0.92). A higher wound complication rate was found in the PSR group (17% vs. 34%; p = 0.047). The RR (Relative Risk) of wound events for PSR was 2.42 (95% CI 1.09-5.35; p = 0.0296).Conclusions To date, not only there is no data supporting PSR after laparoscopy in advanced ovarian cancer, but the role of PSM+ in prognosis also remains unclear. In patients in which laparoscopy is performed prior to the debulking procedure, the PSR may not be recommended in those cases of no macroscopic port site metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.suronc.2019.01.007

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In advanced ovarian cancer, post-laparotomy port-site excision increased the risk of wound complications and had no beneficial effect on survival.

    “They discovered that port-site excision increased the risk of wound complications and had no beneficial effect on survival [25].”

    From Insights Into Laparoscopic Port Site Complications: A Comprehensive Review (2024) · cites this paper as [25]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Lago, V., Gimenez, L., Matute, L., Padilla-Iserte, P., Cárdenas-Rebollo, J. M., Gurrea, M., Montero, B., Montoliu, G., & Domingo, S.
Affiliations
Hospital Universitari i Politècnic La Fe (ES)
Corresponding author
Lago, Víctor
ORCID
Venue
Surgical Oncology
Publisher
Elsevier BV
Published
2019-06
Volume
29
Pages
1-6
ISSN
0960-7404 (ISSN-L)
DOI
10.1016/j.suronc.2019.01.007
OpenAlex
W2914433329
Cited by
18
References
17
Citations by year
2026: 3 · 2024: 6 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 3
FWCI
1.68
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Surgical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
port-site metastasis, advanced ovarian cancer, laparoscopic surgery, cytoreductive surgery, wound complications, survival outcomes
MeSH terms
Aged, Female, Follow-Up Studies, Humans, Male, Ovarian Neoplasms, Laparoscopy, Prognosis, Retrospective Studies, Survival Rate, Cystadenocarcinoma, Serous, Cytoreduction Surgical Procedures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review